SERDA therapeutics

Amsterdam, The Netherlands

SERDA Therapeutics develops a wound debridement solution specifically designed to treat severe burn injuries and persistent ulcers.

$2.2M raised

Jun 2024

Seed

Pharmaceutical

Top Investors

NLC

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SERDA therapeutics

How much funding has SERDA therapeutics raised?

SERDA therapeutics has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in June 2024.

Who are SERDA therapeutics's investors?

SERDA therapeutics's investors include NLC.

Where is SERDA therapeutics headquartered?

SERDA therapeutics is headquartered in Amsterdam, The Netherlands.

What does SERDA therapeutics do?

SERDA Therapeutics develops a wound debridement solution specifically designed to treat severe burn injuries and persistent ulcers.

What stage is SERDA therapeutics at?

SERDA therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 3, 2024.

MLA

"SERDA therapeutics — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/serda-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). SERDA therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/serda-therapeutics

Wikipedia (cite web)

{{cite web |title=SERDA therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/serda-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 3, 2024.

Similar Companies in Pharmaceutical

View all

Cannabinoid API Solutions

Blue Sky Specialty Pharmacy

Mount Pleasant$10.0M